Thanks for emailing that article!
The annual Daniel Scott Weston Glaucoma Research Lecture was held at the Moldaw Residences in Palo Alto, CA on October 7, 2014.
The featured speaker, Catalyst for a Cure Principal Investigator Andrew D. Huberman, PhD, highlighted the latest developments in the team's study to find new and sensitive glaucoma biomarkers.
Dr. Huberman’s presentation ‘ Neurons: The Canary in the Coal Mine’ provided an update on his laboratory’s study of retinal ganglion cells and their efforts to identify the cells that are among the earliest to show changes in glaucoma. Our Catalyst for a Cure researchers believe they can find more effective ways to diagnose and manage glaucoma, before irrevocable vision loss.
Established in 2007 with a grant from Gladys and George Weston, DDS, the lecture showcases a nationally recognized clinician or scientist whose work is significantly advancing our knowledge of glaucoma, particularly in the area of new therapies and progress toward a cure.
Dr. Weston introduced Dr. Huberman to more than 50 engaged attendees, including Glaucoma Research Foundation Board members Bill Stewart, Mona Zander and Art Takahara, and Catalyst Circle members Margaret and Russell Garvin, Anthony Fisher, PhD, and Steven Kirsch. Following Dr. Huberman’s presentation the audience participated in an informative question and answer session.
Thomas Brunner noted, “We are very grateful for the Weston’s continued commitment to hosting this annual lecture, reconnecting donors, volunteers and friends in Silicon Valley and showcasing the promising work in the field of glaucoma research. We are so pleased to have the opportunity to highlight the extraordinary progress of our Catalyst for a Cure team.”
Last reviewed on October 29, 2017
This article appeared in the January 2015 issue of Gleams.Subscribe